BioSpace News Archive

Genetown

UPDATE -- Noema Pharma to Attend and Present at 41st Annual J.P. Morgan Healthcare Conference in San Francisco

Noema Pharma announced that members of the Management Team will attend and present at the 41st Annual J.P. Morgan Healthcare Conference taking place on January 9-12, 2023 in San Francisco, CA.

January 5, 2023
·
1 min read
BioMidwest

Life Spine Announces First Surgical Cases of ARx® Spinal Fixation System

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the first surgical cases of ARx Spinal Fixation System.

January 5, 2023
·
2 min read
Biotech Bay

Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets

Alveo Technologies, Inc. announced it has signed a Memorandum of Understanding with the Barbados Investment and Development Corporation to co-develop on its novel molecular sensing platform, while contributing to the growth of the life sciences industry in the Caribbean nation.

January 5, 2023
·
4 min read
ScribeEMR Receives SOC type 2 Certification in Recognition of Security System Integrity

ScribeEMR, a leading provider of real-time medical scribe and practice management services, has been certified SOC type 2 compliant.

January 5, 2023
·
2 min read
BioMidwest

Xeris Biopharma to Present at 41st Annual J.P. Morgan Healthcare Conference

Xeris Biopharma Holdings, Inc. announced that Paul R. Edick, Xeris’ Chairman and CEO, will present an overview of the Company at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 12:00 pm Pacific Time.

January 5, 2023
·
3 min read
Genetown

Alnylam Announces Updates to its Board of Directors

Alnylam Pharmaceuticals, Inc. the leading RNAi therapeutics company, announces appointment of Carolyn Bertozzi, Ph.D. a Nobel Laureate to the Board.

January 5, 2023
·
8 min read
Business

Spruce Biosciences and Kaken Pharmaceutical Announce Strategic Partnership and Exclusive Licensing Agreement to Develop and Commercialize Tildacerfont for CAH in Japan

Spruce Biosciences, Inc. and Kaken Pharmaceutical Co. Ltd announced that the companies have entered into an exclusive licensing agreement for the development and commercialization of Spruce’s product candidate, tildacerfont, for the treatment of congenial adrenal hyperplasia in Japan.

January 5, 2023
·
6 min read
Business

Marinus Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 ZTALMY® Net Product Revenue and Provides Business Update

Marinus Pharmaceuticals, Inc. reported business highlights and preliminary U.S. ZTALMY® net product revenue for the fourth quarter and year ended December 31, 2022.

January 5, 2023
·
6 min read
Biotech Bay

Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics

Moderna, Inc. and CytomX Therapeutics, Inc. announced a collaboration and licensing agreement to create investigational mRNA-based conditionally activated therapies utilizing Moderna’s mRNA technologies and CytomX’s Probody® therapeutic platform.

January 5, 2023
·
10 min read
Genetown

GENFIT to Participate in Upcoming Investor Conferences - Jan 05, 2023

GENFIT, a late-stage biopharmaceutical company dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs, announced that management will participate in upcoming investor conferences.

January 5, 2023
·
5 min read